Natera, Inc. NTRA Oncology — Revenue recognized
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Natera, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.
The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Natera, Inc.'s oncology — revenue recognized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Natera, Inc.'s oncology — revenue recognized?
- Natera, Inc. (NTRA) reported oncology — revenue recognized of $100K in Q1 2026.
- What does oncology — revenue recognized mean?
- This metric measures the total revenue recognized during the reporting period specifically attributable to oncology assay interpretation services. It reflects the value of services delivered to customers, such as clinical laboratories or healthcare providers, in accordance with the company's revenue recognition policies. This is a primary indicator of the commercial adoption and market penetration of the company's oncology diagnostic portfolio.